Search

everythinglearnresearchcommunity

for

Search:↓

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

This is the first known case of parathyroid cancer in a patient with Birt Hogg Dube Syndrome.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

A woman with a long-term skin condition developed a serious skin cancer that led to her death.

Older men with scalp wounds had long-term healing problems after using imiquimod or diclofenac for skin cancer prevention.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Wnt-activating drugs generally do not increase cancer risk.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

3D bioprinted lung cancer models in a mouse-like structure offer a better way to study radiation effects without using live animals.

Scalp cooling effectively prevents hair loss during chemotherapy in most cases.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Patients with chronic kidney disease often have various skin problems that affect their quality of life, but early treatment can help.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.